Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Change in Accured Expenses (2017 - 2022)

Historic Change in Accured Expenses for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $608000.0.

  • Iterum Therapeutics' Change in Accured Expenses rose 24373.52% to $608000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $3.2 million, marking a year-over-year increase of 38642.09%. This contributed to the annual value of -$5.1 million for FY2024, which is 24646.03% down from last year.
  • Iterum Therapeutics' Change in Accured Expenses amounted to $608000.0 in Q4 2022, which was up 24373.52% from $780000.0 recorded in Q3 2022.
  • Over the past 5 years, Iterum Therapeutics' Change in Accured Expenses peaked at $5.3 million during Q2 2019, and registered a low of -$6.2 million during Q1 2020.
  • In the last 5 years, Iterum Therapeutics' Change in Accured Expenses had a median value of $238000.0 in 2021 and averaged $18400.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 97993.31% in 2019, then tumbled by 47388.69% in 2020.
  • Iterum Therapeutics' Change in Accured Expenses (Quarter) stood at $1.7 million in 2018, then plummeted by 226.47% to -$2.2 million in 2019, then soared by 81.69% to -$399000.0 in 2020, then decreased by 6.02% to -$423000.0 in 2021, then surged by 243.74% to $608000.0 in 2022.
  • Its last three reported values are $608000.0 in Q4 2022, $780000.0 for Q3 2022, and $987000.0 during Q2 2022.